Medical and Pharmaceutical Poor people die of cancer more than rich: UK research Nearly half of the 28,400 additional cancer deaths linked to deprivation are due to lung cancer Joseph MortonFebruary 24, 2025
Health & Wellness Grail shares jump on partnership with Quest Diagnostics The test operates on the principle that cancers shed DNA into the bloodstream Joseph MortonFebruary 14, 2025
Medical and Pharmaceutical Early lung cancer diagnosis saves 52-year-old Indian man’s life A persistent cough and breathlessness while climbing stairs prompted him to visit the hospital Rowan DunneFebruary 13, 2025
Medical and Pharmaceutical PEI needs to jump on lung cancer screening bandwagon ASAP, advocate says It is the last Canadian province without a program for catching the disease Rowan DunneFebruary 10, 2025
Health & Wellness The Canadian healthcare system leaves cancer patients with considerable out of pocket expenses The data also noted that 23 per cent of Canadians diagnosed with cancer Joseph MortonFebruary 6, 2025
Medical and Pharmaceutical FDA gives Zai Lab’s small cell lung cancer therapeutic orphan drug designation About 372,000 people are diagnosed with SCLC annually worldwide Rowan DunneJanuary 27, 2025
AI and Autonomy Behemoth AI project ‘Stargate’ to revolutionize cancer treatment, Ellison claims Trump's newly announced US$500-billion-dollar AI initiative could make custom-tailored vaccines a reality Rowan DunneJanuary 24, 2025
Medical and Pharmaceutical University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year Joseph MortonJanuary 21, 2025
Medical and Pharmaceutical South Korean researchers come up with novel treatment option for lung cancer Non-small cell lung cancer constitutes 85 per cent of all lung cancer cases Joseph MortonJanuary 16, 2025
Medical and Pharmaceutical Phio Pharmaceuticals skyrockets on skin cancer drug trial success Shareholders are having a pretty stellar Monday with the immense gains Rowan DunneJanuary 13, 2025